No increase in demyelinating diseases after hepatitis B vaccination
✍ Scribed by Zipp, Frauke; Weil, John G.; Einhäupl, Karl M.
- Book ID
- 109491621
- Publisher
- Nature Publishing Group
- Year
- 1999
- Tongue
- English
- Weight
- 230 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1078-8956
- DOI
- 10.1038/12376
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Patients who undergo transplantation for hepatitis B virus (HBV)-related diseases are treated indefinitely with hepatitis B hyperimmunoglobulin (HBIG) to prevent endogenous HBV reinfection of the graft. Active immunization with standard hepatitis B vaccines in these patients has recently been report
Fifty children with malignant diseases were vaccinated against hepatitis B. Twenty-nine children suffered from leukaemia or non-Hodgkin's lymphoma; 14 of these were on intensive chemotherapy (group I) and 15 were without intensive therapy (group II). The other 21 children had various forms of solid